A detailed history of Transform Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Transform Wealth, LLC holds 89,303 shares of NVO stock, worth $10.1 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
89,303
Previous 86,953 2.7%
Holding current value
$10.1 Million
Previous $12.4 Million 14.33%
% of portfolio
0.73%
Previous 0.95%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $279,814 - $341,736
2,350 Added 2.7%
89,303 $10.6 Million
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $261,004 - $312,477
2,127 Added 2.51%
86,953 $12.4 Million
Q1 2024

Apr 15, 2024

SELL
$102.11 - $135.92 $36,146 - $48,115
-354 Reduced 0.42%
84,826 $10.9 Million
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $312,672 - $375,612
3,562 Added 4.36%
85,180 $8.81 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $4.1 Million - $8.99 Million
45,069 Added 123.31%
81,618 $7.42 Million
Q2 2023

Jul 13, 2023

BUY
$155.98 - $172.65 $5.5 Million - $6.09 Million
35,258 Added 2731.06%
36,549 $5.91 Million
Q1 2023

Apr 14, 2023

BUY
$132.34 - $159.14 $170,850 - $205,449
1,291 New
1,291 $205,000
Q4 2018

Jan 30, 2019

SELL
$41.54 - $47.25 $756,028 - $859,950
-18,200 Closed
0 $0
Q3 2018

Oct 25, 2018

SELL
$46.76 - $51.24 $458,248 - $502,152
-9,800 Reduced 35.0%
18,200 $858,000
Q2 2018

Aug 03, 2018

SELL
$44.29 - $50.42 $1.73 Million - $1.97 Million
-39,000 Reduced 58.21%
28,000 $1.29 Million
Q1 2018

May 03, 2018

SELL
$48.49 - $58.14 $77,584 - $93,024
-1,600 Reduced 2.33%
67,000 $3.3 Million
Q4 2017

Feb 08, 2018

BUY
$47.53 - $53.73 $3.26 Million - $3.69 Million
68,600
68,600 $3.68 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Transform Wealth, LLC Portfolio

Follow Transform Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.